Section 32 — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Executive Officer, Director, Promoter)Kevin Heyries(Executive Officer)Diana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)
BoardVijay S. Pande(Director)in
Co-investorsAndreessen HorowitzArtis VenturesObvious VenturesS32NVentures
Stairwell provides cybersecurity threat intelligence solutions to help teams identify and address security threats.
Cybersecurity
Co-investorsAccelBallistic VenturesGradient VenturesS32Lux CapitalSequoia Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.